These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20050820)

  • 1. Physical activity and lung cancer among non-smokers: a pilot molecular epidemiological study within EPIC.
    Rundle A; Richie J; Steindorf K; Peluso M; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen JP; Boeing H; Trichopoulou A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Tormo MJ; Quiros J; Agudo A; Berglund G; Jarvholm B; Bingham S; Key TJ; Gormally E; Saracci R; Kaaks R; Riboli E; Vineis P
    Biomarkers; 2010 Feb; 15(1):20-30. PubMed ID: 20050820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study.
    Perera FP; Mooney LA; Stampfer M; Phillips DH; Bell DA; Rundle A; Cho S; Tsai WY; Ma J; Blackwood A; Tang D;
    Carcinogenesis; 2002 Oct; 23(10):1641-6. PubMed ID: 12376472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers.
    Tang DL; Rundle A; Warburton D; Santella RM; Tsai WY; Chiamprasert S; Hsu YZ; Perera FP
    Carcinogenesis; 1998 Nov; 19(11):1949-53. PubMed ID: 9855008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study.
    Peluso M; Airoldi L; Munnia A; Colombi A; Veglia F; Autrup H; Dunning A; Garte S; Gormally E; Malaveille C; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita BH; Peeters PH; Kumle M; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Tormo MJ; Quiros JR; Berglund G; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Bingham S; Vineis P
    Br J Nutr; 2008 Sep; 100(3):489-95. PubMed ID: 18275627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular epidemiological case-control study of lung cancer.
    Tang D; Santella RM; Blackwood AM; Young TL; Mayer J; Jaretzki A; Grantham S; Tsai WY; Perera FP
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):341-6. PubMed ID: 7655328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulky DNA adducts and breast cancer risk in the prospective EPIC-Italy study.
    Saieva C; Peluso M; Masala G; Munnia A; Ceroti M; Piro S; Sera F; Bendinelli B; Pala V; Sieri S; Tumino R; Giurdanella MC; Panico S; Mattiello A; Vineis P; Polidoro S; Matullo G; Palli D
    Breast Cancer Res Treat; 2011 Sep; 129(2):477-84. PubMed ID: 21452020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA adducts and lung cancer risk: a prospective study.
    Peluso M; Munnia A; Hoek G; Krzyzanowski M; Veglia F; Airoldi L; Autrup H; Dunning A; Garte S; Hainaut P; Malaveille C; Gormally E; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Trichopoulos D; Kaladidi A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Kumle M; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quiros JR; Berglund G; Janzon L; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Vineis P
    Cancer Res; 2005 Sep; 65(17):8042-8. PubMed ID: 16140979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort.
    Steindorf K; Friedenreich C; Linseisen J; Rohrmann S; Rundle A; Veglia F; Vineis P; Johnsen NF; Tjønneland A; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Boutron-Ruault MC; Schulz M; Boeing H; Trichopoulou A; Kalapothaki V; Koliva M; Krogh V; Palli D; Tumino R; Panico S; Monninkhof E; Peeters PH; Boshuizen HC; Bueno-de-Mesquita HB; Chirlaque MD; Agudo A; Larrañaga N; Quirós JR; Martínez C; Barricarte A; Janzon L; Berglund G; Bingham S; Khaw KT; Key TJ; Norat T; Jenab M; Cust A; Riboli E
    Int J Cancer; 2006 Nov; 119(10):2389-97. PubMed ID: 16894558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort.
    Gilberson T; Peluso ME; Munia A; Luján-Barroso L; Sánchez MJ; Navarro C; Amiano P; Barricarte A; Quirós JR; Molina-Montes E; Sánchez-Cantalejo E; Tormo MJ; Chirlaque MD; Ardanaz E; Dorronsoro M; Confortini M; Bonet C; Sala N; González CA; Agudo A
    Carcinogenesis; 2014 Sep; 35(9):2047-54. PubMed ID: 24845263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls.
    Perera F; Mayer J; Jaretzki A; Hearne S; Brenner D; Young TL; Fischman HK; Grimes M; Grantham S; Tang MX
    Cancer Res; 1989 Aug; 49(16):4446-51. PubMed ID: 2743334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study.
    Tang D; Phillips DH; Stampfer M; Mooney LA; Hsu Y; Cho S; Tsai WY; Ma J; Cole KJ; Shé MN; Perera FP
    Cancer Res; 2001 Sep; 61(18):6708-12. PubMed ID: 11559540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis.
    Veglia F; Loft S; Matullo G; Peluso M; Munnia A; Perera F; Phillips DH; Tang D; Autrup H; Raaschou-Nielsen O; Tjønneland A; Vineis P;
    Carcinogenesis; 2008 May; 29(5):932-6. PubMed ID: 18343884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air pollution and risk of lung cancer in a prospective study in Europe.
    Vineis P; Hoek G; Krzyzanowski M; Vigna-Taglianti F; Veglia F; Airoldi L; Autrup H; Dunning A; Garte S; Hainaut P; Malaveille C; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund EE; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Cirera L; Quiros JR; Berglund G; Forsberg B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E
    Int J Cancer; 2006 Jul; 119(1):169-74. PubMed ID: 16463382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphenol associated-DNA adducts in lung and blood mononuclear cells from lung cancer patients.
    Várkonyi A; Kelsey K; Semey K; Bodell WJ; Lévay G; Mark E; Wain JC; Christiani DC; Wiencke JK
    Cancer Lett; 2006 May; 236(1):24-31. PubMed ID: 15967573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.
    Wei Q; Cheng L; Amos CI; Wang LE; Guo Z; Hong WK; Spitz MR
    J Natl Cancer Inst; 2000 Nov; 92(21):1764-72. PubMed ID: 11058619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
    Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
    Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation.
    Vineis P; Kogevinas M; Simonato L; Brennan P; Boffetta P
    Mutat Res; 2000 Jul; 463(1):103-10. PubMed ID: 10928863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.